How to Create and Use Target Product Profiles to Guide Vaccine Development

This engaging two-hour workshop will be of great interest to all VALIDATE members, especially those involved in translational vaccine research, product development, clinical development, or vaccine implementation, and those interested in understanding how Target Product Profiles can help guide vaccine development from early research through to real-world impact.

It will cover:

• What a Target Product Profile is, and why it is important for guiding vaccine development
• Which product attributes and characteristics should be included in a TPP
• How minimum and preferred performance criteria are agreed with disease experts, potential end users, implementers, payers and other stakeholders
• The difference between an intervention-level TPP and a TPP for a specific clinical candidate
• How TPPs evolve as evidence, priorities and development pathways change
• How TPPs can support go/no-go decision-making during clinical candidate development

Register below to secure your place for this valuable opportunity to hear from leading experts on a topic that is often overlooked, but essential for vaccine researchers working to translate research into real-world impact.

This Workshop will be facilitated by:

Janet White, Portfolio & Platform Lead, Global Health, Gates Foundation

Dr Alexander Schmidt, Chief Medical Officer and Head of Development, Gates Medical Research Institute

Dr Ajoy Chakrabarti, Portfolio & Platform Lead, Polio and Vaccine Development, Gates Foundation